Malignant coronary vasospasm refractory to nitrates: Using clevidipine as an emergent coronary vasodilator.

Autor:	Persia-Paulino YR; Department of Heart Area, Cardiology, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain., Cuevas-Pérez J; Department of Heart Area, Cardiology, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain., Fernández-Asensio R; Department of Heart Area, Cardiology, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain., Junco-Vicente A; Department of Heart Area, Cardiology, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain., Iglesias-Fraile L; Department of Heart Area, Intensive Cardiovascular Care, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain., Ayesta A; Department of Heart Area, Cardiology, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain.
Jazyk:	angličtina
Zdroj:	Archivos de cardiologia de Mexico [Arch Cardiol Mex] 2022 Oct 21; Vol. 92 (4), pp. 537-540. Date of Electronic Publication: 2022 Oct 21.
DOI:	10.24875/ACM.21000251
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu